JPS6016924A - 抗腫瘍剤 - Google Patents
抗腫瘍剤Info
- Publication number
- JPS6016924A JPS6016924A JP58125726A JP12572683A JPS6016924A JP S6016924 A JPS6016924 A JP S6016924A JP 58125726 A JP58125726 A JP 58125726A JP 12572683 A JP12572683 A JP 12572683A JP S6016924 A JPS6016924 A JP S6016924A
- Authority
- JP
- Japan
- Prior art keywords
- compound
- antineoplastic agent
- group
- formula
- lower alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002246 antineoplastic agent Substances 0.000 title abstract description 19
- 229940034982 antineoplastic agent Drugs 0.000 title abstract 5
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 7
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims abstract description 3
- 239000002075 main ingredient Substances 0.000 claims description 6
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 5
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 5
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 4
- 125000003277 amino group Chemical group 0.000 claims description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 3
- 150000001875 compounds Chemical class 0.000 abstract description 24
- 150000002291 germanium compounds Chemical class 0.000 abstract description 10
- 206010028980 Neoplasm Diseases 0.000 abstract description 6
- 201000009030 Carcinoma Diseases 0.000 abstract description 4
- 230000000694 effects Effects 0.000 abstract description 4
- 241001465754 Metazoa Species 0.000 abstract description 3
- 238000002474 experimental method Methods 0.000 abstract description 3
- 230000001747 exhibiting effect Effects 0.000 abstract 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 abstract 1
- 238000000034 method Methods 0.000 description 8
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 241000699670 Mus sp. Species 0.000 description 6
- 125000001424 substituent group Chemical group 0.000 description 5
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- -1 carboxydiethylgermanium Chemical compound 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 229910052732 germanium Inorganic materials 0.000 description 3
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 3
- 229910000037 hydrogen sulfide Inorganic materials 0.000 description 3
- 230000001766 physiological effect Effects 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- XRYJTKGEJGVBCC-UHFFFAOYSA-N 2-germylpropanoic acid Chemical class CC([GeH3])C(O)=O XRYJTKGEJGVBCC-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical class C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 125000004434 sulfur atom Chemical group 0.000 description 2
- MUDDKLJPADVVKF-UHFFFAOYSA-N trichlorogermane Chemical compound Cl[GeH](Cl)Cl MUDDKLJPADVVKF-UHFFFAOYSA-N 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- RYHBNJHYFVUHQT-SVYQBANQSA-N (2H8)-1,4-Dioxane Chemical compound [2H]C1([2H])OC([2H])([2H])C([2H])([2H])OC1([2H])[2H] RYHBNJHYFVUHQT-SVYQBANQSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- IQULGZQMMPRBLA-UHFFFAOYSA-N 2-carboxyethylgermanium Chemical compound OC(=O)CC[Ge] IQULGZQMMPRBLA-UHFFFAOYSA-N 0.000 description 1
- NLIJOIUVZBYQRS-UHFFFAOYSA-N 3-trichlorogermylpropanoic acid Chemical compound OC(=O)CC[Ge](Cl)(Cl)Cl NLIJOIUVZBYQRS-UHFFFAOYSA-N 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical class NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 206010042135 Stomatitis necrotising Diseases 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000003926 acrylamides Chemical class 0.000 description 1
- 238000007259 addition reaction Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 description 1
- 201000008585 noma Diseases 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 230000002100 tumorsuppressive effect Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/30—Germanium compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP58125726A JPS6016924A (ja) | 1983-07-11 | 1983-07-11 | 抗腫瘍剤 |
| GB08416634A GB2143128B (en) | 1983-07-11 | 1984-06-29 | Antineoplastic organogermanium compounds |
| DE19843425404 DE3425404A1 (de) | 1983-07-11 | 1984-07-10 | Antineoplastikum |
| CH3344/84A CH661661A5 (fr) | 1983-07-11 | 1984-07-10 | Agent antineoplasique. |
| FR8411038A FR2549066B1 (fr) | 1983-07-11 | 1984-07-11 | Nouveau compose d'organogermanium utile comme agent antineoplastique |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP58125726A JPS6016924A (ja) | 1983-07-11 | 1983-07-11 | 抗腫瘍剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS6016924A true JPS6016924A (ja) | 1985-01-28 |
| JPS6158449B2 JPS6158449B2 (fr) | 1986-12-11 |
Family
ID=14917251
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP58125726A Granted JPS6016924A (ja) | 1983-07-11 | 1983-07-11 | 抗腫瘍剤 |
Country Status (5)
| Country | Link |
|---|---|
| JP (1) | JPS6016924A (fr) |
| CH (1) | CH661661A5 (fr) |
| DE (1) | DE3425404A1 (fr) |
| FR (1) | FR2549066B1 (fr) |
| GB (1) | GB2143128B (fr) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60226592A (ja) * | 1984-04-25 | 1985-11-11 | Asai Gerumaniumu Kenkyusho:Kk | 抗酸化剤 |
| JPS61145115A (ja) * | 1984-12-18 | 1986-07-02 | Asai Gerumaniumu Kenkyusho:Kk | 塵肺症患者用風邪症候群予防剤 |
| US4772628A (en) * | 1985-12-28 | 1988-09-20 | Asai Germanium Research Institute | Organogermanium compound and antitumor agent composed mainly of this compound |
| JPS63107920A (ja) * | 1986-06-18 | 1988-05-12 | Asai Gerumaniumu Kenkyusho:Kk | 骨芽細胞活性化剤 |
| US4973553A (en) * | 1987-09-09 | 1990-11-27 | Asai Germanium Research Institute | Salt or organogermanium compound and medicine containing the same |
| JPH01117801A (ja) * | 1987-10-29 | 1989-05-10 | Asai Gerumaniumu Kenkyusho:Kk | 分離臓器洗浄保存液 |
| CA1314210C (fr) * | 1987-10-29 | 1993-03-09 | Norihiro Kakimoto | Agent pour stimuler les fonctions des organes reduites par une mauvaise circulation sanguine |
| JP2698870B2 (ja) * | 1987-10-29 | 1998-01-19 | 株式会社浅井ゲルマニウム研究所 | シクロスポリンの投与による腎毒性の軽減剤 |
| JP2652556B2 (ja) * | 1988-08-29 | 1997-09-10 | 株式会社浅井ゲルマニウム研究所 | 有機ゲルマニウム化合物及びその製造方法 |
| AU635045B2 (en) * | 1989-07-20 | 1993-03-11 | Asai Germanium Research Institute Co., Ltd | Agent for preventing and treating opacity of lens |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1793288B1 (de) * | 1968-03-29 | 1971-05-27 | Daiichi Yakuhin Sangyo Kk | Verfahren zur Herstellung von Organogermaniumoxiden |
| US4271084A (en) * | 1978-03-01 | 1981-06-02 | Ryuichi Sato | Germanium-containing organic polymer and the process for the production of the same |
| JPS55122717A (en) * | 1979-03-15 | 1980-09-20 | Asai Gerumaniumu Kenkyusho:Kk | Interferon inducer |
| JPS5935916B2 (ja) * | 1981-06-09 | 1984-08-31 | 紀博 柿本 | 有機ゲルマニウム化合物及びその製造方法 |
| JPS58174391A (ja) * | 1982-04-07 | 1983-10-13 | Daiichi Yakuhin Sangyo Kk | テトラキス〔１−（ｎ−カルボキシメチルカルバモイル）エチルメルカプト〕ゲルマン及びその製造法 |
-
1983
- 1983-07-11 JP JP58125726A patent/JPS6016924A/ja active Granted
-
1984
- 1984-06-29 GB GB08416634A patent/GB2143128B/en not_active Expired
- 1984-07-10 CH CH3344/84A patent/CH661661A5/fr not_active IP Right Cessation
- 1984-07-10 DE DE19843425404 patent/DE3425404A1/de active Granted
- 1984-07-11 FR FR8411038A patent/FR2549066B1/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| CH661661A5 (fr) | 1987-08-14 |
| JPS6158449B2 (fr) | 1986-12-11 |
| GB8416634D0 (en) | 1984-08-01 |
| GB2143128B (en) | 1987-05-20 |
| DE3425404C2 (fr) | 1987-03-05 |
| DE3425404A1 (de) | 1985-01-31 |
| FR2549066B1 (fr) | 1988-07-15 |
| GB2143128A (en) | 1985-02-06 |
| FR2549066A1 (fr) | 1985-01-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH062740B2 (ja) | 医薬用組成物 | |
| JPS6016924A (ja) | 抗腫瘍剤 | |
| KR20190126835A (ko) | Gpr84 수용체 길항제 및 이의 용도 | |
| GB2118176A (en) | Pharmaceutical compositions | |
| US4681960A (en) | Organogermanium compound | |
| US4822817A (en) | Remedy for bone disease | |
| CA2225591A1 (fr) | Complexe de platine (iv) et composition pharmaceutique contenant ce complexe | |
| EP0176005A1 (fr) | Complexes de platine | |
| JPH0340034B2 (fr) | ||
| JPH04500506A (ja) | Ａｃａｔ酵素をブロックするのに有効な二価リガンド類 | |
| US4772628A (en) | Organogermanium compound and antitumor agent composed mainly of this compound | |
| CA1064509A (fr) | Derives substitues de la 2h-pyran-2,6(3h)-dione | |
| JPH01165586A (ja) | 抗腫瘍プロドラッグ | |
| JP3190615B2 (ja) | 放射性医薬品の製造方法及びキット | |
| CA1070616A (fr) | Compose oncolytique | |
| JPS5933292A (ja) | 有機ゲルマニウム化合物 | |
| JPH0370700B2 (fr) | ||
| JPH09500863A (ja) | タモキシフェン抵抗性腫瘍の処置用の非代謝性クロミフェン類似体類 | |
| JPH04264092A (ja) | シクロトリホスファゼンのｎ，ｏスピロ環状誘導体とその製法および用途 | |
| WO2022092068A1 (fr) | Composé carborane, sel de celui-ci ou solvate de celui-ci | |
| JPS61145116A (ja) | オステオポロ−ジス治療剤 | |
| JPH0341492B2 (fr) | ||
| JPS6332359B2 (fr) | ||
| JPS588046A (ja) | サリチル酸誘導体 | |
| JPS62158212A (ja) | 抗腫瘍剤 |